Next Article in Journal
Real-World Outcomes and Biomarker Analysis Based on Routine Clinical, Laboratory, and Pathologic Parameters in Metastatic or Unresectable Esophageal Cancer Treated with First-Line Anti-PD-1 Plus Fluoropyrimidine and Platinum
Previous Article in Journal
Novel MAML2 Fusions in Human Malignancy
 
 
Article

Article Versions Notes

Cancers 2025, 17(19), 3147; https://doi.org/10.3390/cancers17193147
Action Date Notes Link
article pdf uploaded. 27 September 2025 11:30 CEST Version of Record https://www.mdpi.com/2072-6694/17/19/3147/pdf-vor
article supplementary file uploaded. 27 September 2025 11:30 CEST - https://www.mdpi.com/2072-6694/17/19/3147#supplementary
article pdf uploaded. 27 September 2025 11:51 CEST Updated version of record https://www.mdpi.com/2072-6694/17/19/3147/pdf-vor
article xml file uploaded 28 September 2025 11:28 CEST Original file -
article xml uploaded. 28 September 2025 11:28 CEST Update https://www.mdpi.com/2072-6694/17/19/3147/xml
article pdf uploaded. 28 September 2025 11:28 CEST Updated version of record https://www.mdpi.com/2072-6694/17/19/3147/pdf
article html file updated 28 September 2025 11:30 CEST Original file https://www.mdpi.com/2072-6694/17/19/3147/html
Back to TopTop